{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T15:24:36Z","timestamp":1774538676741,"version":"3.50.1"},"reference-count":70,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/j.jsbmb.2003.08.003","type":"journal-article","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T07:58:36Z","timestamp":1069401516000},"page":"111-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells"],"prefix":"10.1016","volume":"87","author":[{"given":"J","family":"Shields-Botella","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Duc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Duranti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F","family":"Puccio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Delansorne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Paris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsbmb.2003.08.003_BIB1","first-page":"502","article-title":"Physiological actions of progesterone in target tissues","volume":"18","author":"Graham","year":"1997","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1526-9523(02)00230-1","article-title":"Progestin contraceptives","volume":"47","author":"Schnare","year":"2002","journal-title":"J. Midwifery Womens Health"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0039-128X(00)00123-9","article-title":"Progesterone and progestins: applications in gynecology","volume":"65","author":"deZiegler","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB4","first-page":"14","article-title":"The rationale for a wider range of progestogens","volume":"3 Suppl. 2","author":"Skouby","year":"2000","journal-title":"Climacteric"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0010-7824(96)00195-3","article-title":"The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and anti-androgenic potential","volume":"54","author":"Fuhrmann","year":"1996","journal-title":"Contraception"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB6","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0039-128X(00)00119-7","article-title":"Nestorone: a progestin with a unique pharmacological profile","volume":"65","author":"Kumar","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0010-7824(94)00003-F","article-title":"Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays","volume":"51","author":"Fuhrmann","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB8","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/BF03349652","article-title":"Structure-activity and structure\u2013affinity relationships of 19-nor-progesterone derivatives in rat uterus","volume":"13","author":"Botella","year":"1990","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB9","first-page":"544","article-title":"The cellular mechanism of the anti-androgenic action of nomegestrol acetate, a new 19-nor progestagen, on the rat prostate","volume":"115","author":"Botella","year":"1987","journal-title":"Acta Endocrinol. (Copenh.)"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB10","unstructured":"R. Delansorne, J. Botella-Shields, I. Duc, E. Duranti, S. Guesdon, S. Galliani, J. Paris, Steroid receptor profile of TX525, a new synthetic progestin, in: Proceedings of the Tenth International Congress on Hormonal Steroids, Quebec, Canada, 1998."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0010-7824(00)00133-5","article-title":"Drospirenone: pharmacology and pharmacokinetics of a unique progestogen","volume":"62","author":"Krattenmacher","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB12","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0010-7824(94)90073-6","article-title":"The progestin ST 1435-rapid metabolism in man","volume":"50","author":"Heikinheimo","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0960-0760(00)00093-5","article-title":"Influence of the substitution of 11-methylene, delta(15), and\/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals","volume":"74","author":"Deckers","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2165\/00003495-199550020-00010","article-title":"Gestodene: a review of its pharmacology, efficacy and tolerability in combined contraceptive preparations","volume":"50","author":"Wilde","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB15","doi-asserted-by":"crossref","first-page":"104S","DOI":"10.1016\/S0002-9343(99)80067-9","article-title":"The androgenicity of progestins","volume":"98","author":"Darney","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB16","doi-asserted-by":"crossref","first-page":"116S","DOI":"10.1016\/S0002-9343(99)80069-2","article-title":"Androgenic effects of oral contraceptives: implications for patient compliance","volume":"98","author":"Jones","year":"1995","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB17","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0008-6363(01)00466-7","article-title":"Estrogen replacement therapy, atherosclerosis, and vascular function","volume":"15","author":"Mikkola","year":"2002","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB18","doi-asserted-by":"crossref","unstructured":"Writing Group for Women\u2019s Health Initiative Investigators, Risks and benefits of estrogen plus progestin in healthy postmenopausal women, principal results from the Women\u2019s Health Initiative Randomized Controlled Trial. JAMA 288 (2002) 321\u2013333.","DOI":"10.1001\/jama.288.3.321"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB19","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/00042192-200201000-00003","article-title":"Progestogens in hormonal replacement therapy: new molecules, risks, and benefits","volume":"9","author":"Sitruk-Ware","year":"2002","journal-title":"Menopause"},{"issue":"Suppl. 6","key":"10.1016\/j.jsbmb.2003.08.003_BIB20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1080\/gye.15.s6.44.52","article-title":"Biological effects of progestins in breast cancer","volume":"15","author":"Pasqualini","year":"2001","journal-title":"Gynecol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/jnci\/92.4.328","article-title":"Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin","volume":"92","author":"Ross","year":"2000","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB22","doi-asserted-by":"crossref","first-page":"3791","DOI":"10.1210\/endo.142.9.8401","article-title":"A-ring reduced metabolites of 19-nor synthetic progestins as subtype selective agonists for ER\u03b1","volume":"142","author":"Larrea","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-2999(01)00893-7","article-title":"In vitro metabolism of gestodene in target organs: formation of A-ring reduced derivatives with oestrogenic activity","volume":"417","author":"Lemus","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB24","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0960-0760(00)00125-4","article-title":"Hormonal properties of norethisterone, 7alpha-methyl-norethisterone and their derivatives","volume":"74","author":"Schoonen","year":"2000","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB25","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/0960-0760(95)00171-U","article-title":"Nomegestrol acetate, a clinically useful 19-norprogesterone derivative which lacks estrogenic activity","volume":"55","author":"Catherino","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB26","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0960-0760(95)00156-T","article-title":"Lack of estrogenic potential of progesterone- or 19-nor-progesterone-derived progestins as opposed to testosterone or 19-nor-testosterone derivatives on endometrial Ishikawa cells","volume":"55","author":"Botella","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0960-0760(94)90170-8","article-title":"Inhibition by nomegestrol acetate and other synthetic progestins on proliferation and progesterone receptor content of T47-D human breast cancer cells","volume":"50","author":"Botella","year":"1994","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB28","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0022-3565(25)39233-5","article-title":"Extinction of mineralocorticoid effects in 19-norprogesterone derivatives: structure-activity relationships","volume":"243","author":"Paris","year":"1987","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB29","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1677\/joe.0.1100037","article-title":"Steroid regulation of Na+\/K+-ATPase activity in the rat kidney: effect of a new 19-nor-progestagen","volume":"110","author":"Botella","year":"1986","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB30","first-page":"710","article-title":"The pharmacological profile of TX 066 (17 alpha-acetoxy-6-methyl-19-nor-4,6-pregna-diene-3,20-dione), a new oral progestative","volume":"33","author":"Paris","year":"1983","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB31","first-page":"699","article-title":"Interaction of new 19 nor progesterone derivatives with progestagen, mineralocorticoid and glucocorticoid cytosolic receptors","volume":"17","author":"Botella","year":"1986","journal-title":"J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB32","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0022-3565(25)23767-3","article-title":"Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative","volume":"248","author":"Botella","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB33","first-page":"2757","article-title":"Zur physiologie und pathologie der sexualhormone im besonderen des hormons des corpus luteum","volume":"54","author":"Clauberg","year":"1930","journal-title":"Zentralbl. Gynakol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB34","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1113\/jphysiol.1934.sp003217","article-title":"The assay of progestin","volume":"83","author":"McPhail","year":"1934","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB35","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0039-128X(91)90055-Z","article-title":"Interaction of [3H] nomegestrol acetate with cytosolic progesterone receptors from the rat uterus","volume":"56","author":"Duc","year":"1991","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB36","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1111\/j.1472-8206.1990.tb00036.x","article-title":"Kinetic analysis of the binding of nomegestrol acetate to the progesterone receptors in rat uterus by competition studies","volume":"4","author":"Botella","year":"1990","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0010-7824(94)00015-O","article-title":"Drospirenone: a novel progestogen with anti-mineralocorticoid and anti-androgenic activity. Pharmacological characterization in animal models","volume":"51","author":"Muhn","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB38","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0010-7824(94)00019-S","article-title":"Comparative progestational activity of norgestimate, levonorgestrel-oxime and levonorgestrel in the rat and binding of these compounds to the progesterone receptor","volume":"51","author":"Kuhnz","year":"1995","journal-title":"Contraception"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB39","doi-asserted-by":"crossref","first-page":"27793","DOI":"10.1074\/jbc.M202584200","article-title":"New human breast cancer cells to study progesterone receptor isoform ratio effects and ligand-independent gene regulation","volume":"277","author":"Jacobsen","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0303-7207(01)00465-8","article-title":"Reproductive functions of the progesterone receptor isoforms: lessons from knock-out mice","volume":"179","author":"Conneely","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB41","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1210\/mend.14.12.0564","article-title":"Ligand-activated progesterone receptor isoform hPR-A is a stronger transactivator than hPR-B for the expression of IGFBP-1 (insulin-like growth factor binding protein-1) in human endometrial stromal cells","volume":"14","author":"Gao","year":"2000","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB42","first-page":"70","article-title":"Anti-androgenic properties of nomegestrol acetate","volume":"5","author":"Duc","year":"1995","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB43","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0960-0760(02)00192-9","article-title":"The intrinsic transcriptional estrogenic activity of a non-phenolic derivative of levonorgestrel is mediated via the estrogen receptor-\u03b1","volume":"82","author":"Garcia-Becerra","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB44","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1677\/joe.0.1650693","article-title":"The oestrogenic effects of gestodene, a potent contraceptive progestin, are mediated by its A-ring reduced metabolites","volume":"165","author":"Lemus","year":"2000","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB45","first-page":"2771","article-title":"Effects of steroid hormones and antisteroids on alkaline phosphatase activity in human endometrial cancer cells (Ishikawa line)","volume":"46","author":"Holinka","year":"1986","journal-title":"Cancer Res."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB46","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1210\/endo.137.4.8625916","article-title":"Regulation of estrogen sulfotransferase in human endometrial adenocarcinoma cells by progesterone","volume":"137","author":"Falany","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB47","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1093\/humrep\/16.5.1030","article-title":"Assessment of oestrogenic potency of chemicals used as growth promoter by in-vitro methods","volume":"16","author":"Le Guevel","year":"2001","journal-title":"Hum. Reprod."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB48","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1101\/gad.9.18.2266","article-title":"Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities","volume":"18","author":"Lydon","year":"1995","journal-title":"Genes Dev."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB49","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1023\/A:1018774302092","article-title":"Estrogen and progestin regulation of cell cycle progression","volume":"1","author":"Sutherland","year":"1998","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB50","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0960-0760(99)00053-9","article-title":"Progestins in the menopause","volume":"69","author":"Sitruk-Ware","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB51","first-page":"127","article-title":"Tibolone versus 17beta-estradiol\/norethisterone: effects on the proliferation of human breast cancer cells","volume":"23","author":"Lippert","year":"2002","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB52","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0960-0760(95)00215-4","article-title":"Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells. I. MCF-7 cell lines","volume":"55","author":"Schoonen","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB53","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0960-0760(95)00216-2","article-title":"Effects of two classes of progestagens, pregnane and 19-nortestosterone derivatives, on cell growth of human breast tumor cells. II. T47D cell lines","volume":"55","author":"Schoonen","year":"1995","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB54","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00441-002-0683-z","article-title":"An in vitro long-term culture model for normal human mammary gland: expression and regulation of steroid receptors","volume":"311","author":"Zhuang","year":"2003","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB55","doi-asserted-by":"crossref","first-page":"30693","DOI":"10.1074\/jbc.270.51.30693","article-title":"Preferential stimulation of human progesterone receptor B expression by estrogen in T-47D human breast cancer cells","volume":"270","author":"Graham","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB56","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0960-0760(02)00027-4","article-title":"Expression of progesterone receptor isoforms A and B is differentially regulated by estrogen in different breast cancer cell lines","volume":"80","author":"Vienonen","year":"2002","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB57","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1677\/erc.0.0070257","article-title":"Apoptosis in mammary gland and cancer","volume":"7","author":"Kumar","year":"2000","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB58","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0960-0760(99)00069-2","article-title":"Proapoptotic effects of anti-estrogens, progestins and androgen in breast cancer cells","volume":"69","author":"Kandouz","year":"1999","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB59","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0039-128X(00)00172-0","article-title":"Hormonal regulation of apoptosis in breast cells and tissues","volume":"65","author":"Gompel","year":"2000","journal-title":"Steroids"},{"issue":"Suppl 4","key":"10.1016\/j.jsbmb.2003.08.003_BIB60","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/S0959-8049(00)00243-4","article-title":"Progesterone receptor activation. an alternative to SERMs in breast cancer","volume":"36","author":"Desreux","year":"2000","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0014-2999(01)01263-8","article-title":"Assessment of the oestrogenic activity of the contraceptive progestin levonorgestrel and its non-phenolic metabolites","volume":"417","author":"Santillan","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB62","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0735-1097(92)90116-5","article-title":"Short-term administration of estrogen and vascular responses of atherosclerotic coronary arteries","volume":"20","author":"Williams","year":"1992","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB63","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0735-1097(96)00524-4","article-title":"Reactivity based coronary vasospasm independent of atherosclerosis in Rhesus monkeys","volume":"29","author":"Hermsmeyer","year":"1997","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB64","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1016\/S0002-9378(98)70149-8","article-title":"Co-administration of nomegestrol acetate does not diminish the beneficial effects of estradiol on coronary artery dilator responses","volume":"179","author":"Williams","year":"1998","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB65","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0039-128X(00)00118-5","article-title":"Nomegestrol acetate and vascular reactivity: nonhuman primate experiments","volume":"65","author":"Paris","year":"2000","journal-title":"Steroids"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB66","first-page":"187","article-title":"Short term effects on lipids and lipoproteins of two progestogens used in postmenopausal replacement therapy","volume":"3","author":"Dorangeon","year":"1992","journal-title":"Eur. J. Clin. Res."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB67","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0015-0282(16)57909-6","article-title":"Cardiovascular risk factors and combined estrogen-progestin replacement therapy: a placebo-controlled study with nomegestrol acetate and estradiol","volume":"64","author":"Conard","year":"1995","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB68","first-page":"216","article-title":"Effects of a 19-norprogesterone derivative, the fourth decade nomegestrol acetate, on lipids","volume":"64","author":"Pelissier","year":"2003","journal-title":"Ann. Endocrinol. (Paris)"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB69","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/0010-7824(91)90080-Y","article-title":"Effects of nomegestrol acetate (5 mg\/d) on hormonal, metabolic and hemostatic parameters in premenopausal women","volume":"44","author":"Basdevant","year":"1991","journal-title":"Contraception"},{"key":"10.1016\/j.jsbmb.2003.08.003_BIB70","first-page":"441","article-title":"Effects of nomegestrol acetate on carbohydrate metabolism","volume":"19","author":"Dorangeon","year":"1993","journal-title":"Diabet. Metab."}],"container-title":["The Journal of Steroid Biochemistry and Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076003004102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960076003004102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:45:23Z","timestamp":1760733923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960076003004102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":70,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0960076003004102"],"URL":"https:\/\/doi.org\/10.1016\/j.jsbmb.2003.08.003","relation":{},"ISSN":["0960-0760"],"issn-type":[{"value":"0960-0760","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An overview of nomegestrol acetate selective receptor binding and lack of estrogenic action on hormone-dependent cancer cells","name":"articletitle","label":"Article Title"},{"value":"The Journal of Steroid Biochemistry and Molecular Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsbmb.2003.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}